Table 1 Patient characteristics in women with primary ovarian cancer who underwent resection of the rectosigmoid colon (N = 770)
From: Anastomotic leakage after resection of the rectosigmoid colon in primary ovarian cancer
Variables | No. (%) |
|---|---|
Age at surgery, years | 55 (48–63)* |
 Mean ± SD | 55.2 ± 10.8 |
 < 60 years | 487 (63.2) |
 ≥ 60 years | 283 (36.7) |
BMI, kg/m 2 | Â |
 low < 18.5 | 50 (6.5) |
 normal: 18.5–24.9 | 542 (70.4) |
 high ≥: 25 | 178 (23.1) |
Diabetes | 44 (5.7) |
Serum albumin level (g/dL) | 4.1 (3.8–4.4)* |
ASA | Â |
 1 | 309 (40.1) |
 2 | 414 (53.8) |
 3 or more | 47 (6.1) |
Stage (FIGO 2014) | Â |
 IC-IIB | 85 (11.0) |
 III | 558 (72.5) |
 IV | 127 (16.5) |
Histology | Â |
 High grade serous | 593 (77.0) |
 Endometrioid | 37 (4.8) |
 Clear cell | 38 (4.9) |
 Mucinous | 13 (1.7) |
 Low grade serous | 2 (0.3) |
 Others | 87 (11.3) |
The interval from operation to adjuvant chemotherapy (days) | 21 (17–27)* |
Use of Intraperitoneal chemotherapy | Â |
 No | 736 (95.6) |
 Yes | 34 (4.4) |
Use of Bevacizumab | Â |
 No | 727 (94.4) |
 Yes | 43 (5.6) |